SCHEMBL24294347

SCHEMBL24294347

CCC1CC2(CCC(NC)CC2)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22704533 0.90 POLB (0.31)
SCHEMBL22704535 0.88 POLB (0.30)
SCHEMBL22704530 0.85 KDM4E (0.36)
SCHEMBL22704503 0.83 KDM4E (0.39)
SCHEMBL22704497 0.82
SCHEMBL22704536 0.82 KDM4E (0.34)
SCHEMBL22704481 0.82 KDM4E (0.34)
SCHEMBL22849851 0.82 NCF1 (0.30)
SCHEMBL26370220 0.79
SCHEMBL22704499 0.78 POLB (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11807636-B2 IRAK degraders and uses thereof KYMERA THERAPEUTICS, INC. (US) 2023-11-07 US disclosed
EP-3971176-A1 AROMATIC AMINE AR AND BET TARGETING PROTEIN DEGRADATION CHIMERA COMPOUND AND USE Hinova Pharmaceuticals Inc. (CN) 2022-03-23 EP disclosed